MyForest Foods | AI Transformation Index

MyForest Foods presents a classic physical-manufacturing durability profile: the business is essentially immune to AI substitution of its core product beca...

MyForest FoodsAgriculture (Agricultural Farm Products)Viking Global Investors

Overview

MyForest Foods grows oyster mushroom mycelium in controlled vertical farms, processes it into whole-cut meat alternatives (MyBacon, MyPulledPork), and sells packaged consumer products to retail and foodservice customers.

Executive Summary

MyForest Foods presents a classic physical-manufacturing durability profile: the business is essentially immune to AI substitution of its core product because it sells something you eat, grown through a proprietary biological process. The AI opportunity is correspondingly limited — this is a food manufacturer where AI can improve operations at the margins but cannot compress the cost structure the way it can in services or information businesses. For a PE investor, the thesis here is built on category positioning in sustainable protein, brand traction at Whole Foods, and proprietary fermentation IP — not on AI transformation potential or AI disruption risk, both of which are structurally low.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

10

Profit Pool Migration

5

Barrier to Entry

5

Disintermediation Exposure

10

Switching Costs

5
Total70.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

2

Improvement Magnitude

2

Transformation Upside

2

Domain Intelligence Amplification

2
Total20.0

37.4

Ciridae AI Score

Durability Rationale

MyForest Foods is structurally durable against AI disruption for the straightforward reason that it makes a physical food product — AI cannot eat, replace, or digitally deliver mycelium bacon. The company sits in the production layer, not a middle layer, so disintermediation risk is essentially nonexistent. The primary durability questions are competitive rather than technological: whether patented fermentation processes and brand positioning can sustain pricing power as the alt-protein category attracts more capital, and whether large CPG incumbents could accelerate into the same space with AI-assisted R&D. These are real competitive risks, but they are not AI disruption risks in the structural sense.

Opportunity Rationale

AI is a relatively modest deal for MyForest Foods because the business is fundamentally a physical food manufacturing operation — the value-creating work happens in vertical farms, on harvesting floors, and in packaging lines, not in cognitive or information-processing workflows. AI's most meaningful contributions are at the margin: optimizing growth environment parameters, improving yield consistency, reducing waste, and sharpening demand forecasting. These are genuine improvements but do not transform the business model, dramatically compress costs, or unlock new markets at scale.

Key Risks

Large CPG players (Tyson, Nestlé, Kraft Heinz) could use AI-accelerated R&D and formulation tools to develop competing mycelium or alt-protein whole-cut products faster and at lower cost, overwhelming MyForest Foods' first-mover advantage and patent protection through sheer capital and distribution scale — making the durability assessment more fragile than the physical-manufacturing moat implies.

The opportunity assessment could be wrong if AI-driven precision fermentation advances (e.g., bioreactor optimization, real-time yield modeling, AI-guided strain development) turn out to compress COGS and improve product quality far more dramatically than expected, making AI a much bigger deal for the production economics of mycelium cultivation than current technology suggests.

Company Overview

Products / Services
Mycelium-based plant protein whole-cut products (MyBacon, MyPulledPork), contract manufacturing and scaled mycelium production services

PE / Ownership History

EventDetails
Ecovative capital to support scaling (~$11M raised by Ecovative)
March 2025
Ecovative raised capital (including external investors) and allocated funds to scale MyForest Foods production and commercialization; grants/loans also reported to support local facility expansion.
Series A-2 ($15M)
June 6, 2023
Series A-2 extension led by parent company Ecovative (capital injected to scale MyBacon distribution and operations); new CEO Greg Shewchuk appointed concurrent with the round. No public, named Partners/Managing Directors from investing firms were disclosed for this transaction.
Venture debt (~$6.7M)
April 2022
Venture loan / debt facility to support working capital and scale production; lender participation disclosed but no named PE deal partners in public announcements.
Series A (~$40M)
April 2021
Large early-stage VC round to scale production and expand retail distribution; multiple VC and strategic investors participated; no public valuation disclosed.
Seed funding round (~$7M)
May 2020
Seed capital raised from early-stage investors and strategic backers to establish initial production and product development.

Executives

NameBackground
Greg Shewchuk
Chief Executive Officer
Former CEO of SpoonfulONE (acquired by Nestlé), senior leadership roles at Campbell Soup Company, Mondelēz/Cadbury, Mead Johnson Nutrition; brought in to scale retail and go-to-market for MyBacon.
Eben Bayer
Co-founder & Chairman
Co-founder of MyForest Foods and Ecovative; inventor/entrepreneur in mycelium technologies with deep technical and product experience in mycelium engineering.
Steve Lomnes
Chief Financial & Strategy Officer (CFSO)
Strategic finance leader focused on capital allocation and scaling food-technology ventures (corporate finance and strategy experience).
Deb Battista
Chief Growth Officer (CGO)
Growth and marketing leader with experience in data-driven brand building and retail/consumer channel expansion.
Adam Heinze
Director of Operations
Operations and production leader with farming and scale-up experience focused on manufacturing and supply chain for mycelium production.
Debra Antonelli
Chief People Officer (CPO)
HR and talent leader responsible for building cross-disciplinary teams spanning biology, production, and commercial operations.